SHANGHAI PHARMACEU
- Market cap
- 5.25B
- P/E (TTM)i
- 7.69
- P/Bi
- 0.45
- EPSi
- 0.92
- Div yieldi
- 4.69%
- 52W posi
- 35%
Anonymous reader poll. Unscientific, not investment advice.
SHANGHAI PHARMACEU last traded at 7.08, little changed on the session. At current prices, the business is worth about 5.25B, the #2085 most valuable US-listed company we track. It pays a dividend yielding 4.69% on a trailing basis. Over the past year the stock has ranged from 6.41 to 8.30; it now sits 35% up that band.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 2 weeks.
- Price is above its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 7.08
- Open
- 6.45
- Day range
- 6.45 - 6.45
- Avg price
- --
- Volume
- 1
- Turnover
- 7
- Turnover ratei
- 0.00%
- Amplitudei
- 0.00%
- 52-week rangei
- 6.41 - 8.30
Valuation
- P/Ei
- --
- P/E (TTM)i
- 7.69
- P/Bi
- 0.45
- EPSi
- 0.92
- Book value / shi
- 15.76
- Net profit
- --
- Net assets
- --
Share structure
- Market cap
- 5.25B
- Float capi
- --
- Shares out
- 741.67M
- Float sharesi
- 741.67M
Dividend & listing
- Div yield (TTM)i
- 4.69%
- Dividend (TTM)
- 0.33
- Listing date
- 1970-01-01
14.7% below the 52-week high
Frequently asked questions
What is the current stock price of SHANGHAI PHARMACEU (SHPMY)?
SHANGHAI PHARMACEU last traded at 7.08. The quote on this page refreshes every few seconds while US markets are open.
What is SHANGHAI PHARMACEU's market cap?
About 5.25B.
What is the P/E ratio of SHANGHAI PHARMACEU?
The trailing twelve-month P/E is 7.69. The Valuation tab shows it against the stock's own five-year range.
Does SHANGHAI PHARMACEU pay a dividend?
Yes. The trailing dividend yield is 4.69%. See the Dividends tab for the full payment history.
What is SHANGHAI PHARMACEU's StockVane Quant Rating?
The StockVane Momentum strategy currently rates SHANGHAI PHARMACEU a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-08 18:50:38 · For reference only, not investment advice and not tailored to your situation.